{"gene":"BANP","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":2021,"finding":"BANP (SMAR1) is a transcription factor that binds the CGCG element (Banp motif) at CpG island promoters in mouse and human genomes. Upon binding to unmethylated CGCG motifs, BANP opens chromatin and phases nucleosomes, activating essential metabolic genes. DNA methylation of the CGCG motif repels BANP binding in vitro and in vivo, epigenetically restricting binding to CpG islands.","method":"Single-molecule footprinting, interaction proteomics, ChIP-seq, in vitro DNA-binding assays with methylated/unmethylated substrates, chromatin accessibility assays in pluripotent and neuronal cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (footprinting, proteomics, ChIP-seq, in vitro binding, functional rescue) in single high-impact study with strong mechanistic validation","pmids":["34234345"],"is_preprint":false},{"year":2023,"finding":"Crystal structure of the BANP BEN domain in apo form and in complex with CGCG-containing DNA revealed that BANP mainly uses electrostatic interactions to bind DNA, with base-specific interactions at TC motifs. The optimal DNA-binding sequence is AAATCTCG. Methylated and unmethylated DNAs are bound with comparable affinity by the isolated BEN domain.","method":"X-ray crystallography, isothermal titration calorimetry, protein binding microarray, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structures of apo and DNA-bound forms, validated by ITC and mutagenesis","pmids":["37086783"],"is_preprint":false},{"year":2024,"finding":"Crystal structures of the BANP BEN domain in complex with cognate DNA substrates revealed that oligomerization is required for BANP to select unmethylated CGCG motif-containing DNA substrates, clarifying the mechanism by which BANP functions as a CpG island-binding protein.","method":"X-ray crystallography of BEN domain–DNA complexes, biochemical oligomerization assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — structural determination with functional validation of oligomerization requirement","pmids":["39225042"],"is_preprint":false},{"year":2022,"finding":"Zebrafish Banp (ortholog of human BANP) directly regulates transcription of DNA replication fork regulator wrnip1 and chromosome segregation regulators cenpt and ncapg via the Banp motif. Loss of Banp activates DNA replication stress and tp53-dependent DNA damage responses leading to apoptosis, and causes defective chromosome segregation (prolonged M-phase) in developing retina.","method":"Zebrafish banp mutants and morphants, RNA-seq, ATAC-seq, identification of Banp-motif-containing target genes, epistasis with tp53","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function in vivo with multiple orthogonal genomic readouts and epistasis analysis","pmids":["35942692"],"is_preprint":false},{"year":2000,"finding":"BANP (originally named SMAR1) was identified as a novel MAR-binding protein that binds the MARbeta scaffold/matrix-associated region located upstream of the TCR beta enhancer. GST-SMAR1 fusion protein binding to MARbeta is competed by MAR-containing DNA from the immunoglobulin kappa locus, demonstrating specificity. The gene maps to mouse chromosome 8 (human 16q24) and produces alternatively spliced transcripts most abundant in thymus.","method":"EMSA (electrophoretic mobility shift assay), GST pulldown, RT-PCR, chromosomal mapping","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct DNA-binding demonstrated by EMSA and competition assay; single lab study","pmids":["10950932"],"is_preprint":false},{"year":2000,"finding":"BANP was identified as a BTG3-associated nuclear protein through a yeast two-hybrid screen using BTG3 as bait, and was localized to human chromosome 16q24, a region showing frequent loss of heterozygosity in tumors.","method":"Yeast two-hybrid screen, chromosomal localization","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 — yeast two-hybrid only; other protein-binding assays did not confirm the interaction","pmids":["10940556"],"is_preprint":false},{"year":2003,"finding":"SMAR1 (BANP) physically interacts with and colocalizes with p53, and overexpression of the short isoform SMAR1(S) activates p53-mediated reporter gene expression and its downstream effector p21, causing G2/M cell-cycle arrest and delaying tumor growth in vivo.","method":"Co-immunoprecipitation, colocalization, reporter gene assays, cell cycle analysis, in vivo tumor growth assay","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP and functional readouts in multiple cell lines and in vivo, single lab","pmids":["12494467"],"is_preprint":false},{"year":2005,"finding":"SMAR1 (BANP) represses cyclin D1 gene expression by recruiting the SIN3/HDAC1 complex and pocket retinoblastoma proteins to the cyclin D1 promoter MAR element, causing chromatin deacetylation spreading at least 5 kb upstream. The interaction is mediated by SMAR1 domain aa 160-350.","method":"Co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — domain mapping, ChIP, Co-IP, functional reporter assays provide multiple orthogonal lines of evidence","pmids":["16166625"],"is_preprint":false},{"year":2005,"finding":"The arginine-serine-rich (RS) domain of SMAR1 (BANP) is phosphorylated by protein kinase C family proteins and is the minimal domain responsible for interaction with, activation, and nuclear stabilization of p53. SMAR1 stabilizes p53 by inhibiting MDM2-mediated degradation. Serine 347 of SMAR1 is the PKC phosphorylation site indispensable for its activity.","method":"Domain deletion/mutagenesis, in vitro phosphorylation assays, co-immunoprecipitation, siRNA knockdown, SMAR1 transgenic mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro phosphorylation, mutagenesis of active site, Co-IP, in vivo transgenic validation","pmids":["15701641"],"is_preprint":false},{"year":2004,"finding":"SMAR1 and Cux/CDP modulate chromatin structure at the MARbeta region (by DNaseI hypersensitivity) and independently repress TCRbeta enhancer-dependent transcription. SMAR1 and Cux physically interact and colocalize in the perinuclear region; repression is enhanced by their co-expression. The repression domain of SMAR1 is distinct from its MAR-binding domain and contains an NLS and RS-rich domain.","method":"DNaseI hypersensitivity, reporter assays, Co-immunoprecipitation, colocalization imaging, domain mapping","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (chromatin accessibility, Co-IP, reporter assays, domain dissection), single lab","pmids":["15371550"],"is_preprint":false},{"year":2009,"finding":"SMAR1 forms a ternary complex with MDM2 and Ser15-phosphorylated p53 in the post-stress recovery phase. This complex recruits HDAC1 to deacetylate p53, causing p53 to bind poorly to target promoters (e.g., p21), switching off the p53 response to allow cell cycle re-entry. SMAR1 knockdown prolongs cell-cycle arrest post-stress.","method":"Co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — ternary complex identified by Co-IP, functional consequence demonstrated by ChIP and cell cycle assays; single lab","pmids":["19303885"],"is_preprint":false},{"year":2010,"finding":"SMAR1 represses BAX and PUMA promoters by binding to an identical MAR element present in both promoters, independently of p53. On mild DNA damage, SMAR1 selectively represses these pro-apoptotic genes via HDAC1-mediated p53 deacetylation, generating cell cycle arrest instead of apoptosis. On severe DNA damage, SMAR1 is sequestered by enlarged PML nuclear bodies, releasing SMAR1 binding and allowing p53 acetylation and apoptosis.","method":"ChIP, reporter assays, Co-IP, siRNA knockdown, PML body imaging, SMAR1 mutant analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, mechanistic switch demonstrated with pathway epistasis; published in high-impact journal","pmids":["20075864"],"is_preprint":false},{"year":2010,"finding":"SMAR1 binds to the HIV-1 LTR MAR element and recruits the HDAC1-mSin3 corepressor complex, tethering the LTR to the nuclear matrix and silencing HIV transcription. Cellular activation by PMA/TNFα dislodges the corepressor, increases histone acetylation, reduces trimethylation, and enables RNA Pol II recruitment.","method":"ChIP, reporter assays, corepressor complex Co-IP, nuclear matrix fractionation, virion production assay","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and functional readouts with mechanistic dissection; single lab","pmids":["20153010"],"is_preprint":false},{"year":2010,"finding":"SMAR1 directly interacts with and inhibits AKR1a4 enzyme activity in the cytoplasm. Upon stress, ATM kinase triggers nuclear translocation of SMAR1, which dissociates the SMAR1-AKR1a4 complex and elevates AKR1a4 activity for free radical scavenging.","method":"Co-immunoprecipitation, enzyme activity assay, subcellular fractionation, ATM inhibitor experiments","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct enzyme inhibition demonstrated biochemically, localization by fractionation; single lab","pmids":["20097305"],"is_preprint":false},{"year":2012,"finding":"TCF-4, β-catenin, and SMAR1 form a complex that tethers the HIV LTR at the -143 nt site, repressing basal HIV promoter activity. Deletion/mutation of this site or knockdown of TCF-4/β-catenin increases basal LTR activity ~5-fold but does not affect Tat-mediated transactivation.","method":"ChIP, luciferase reporter assays, siRNA knockdown, mutant LTR constructs","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and reporter assays with mutational dissection; single lab","pmids":["22674979"],"is_preprint":false},{"year":2014,"finding":"SMAR1 inhibits EMT in breast cancer cells via two mechanisms: (1) transcriptional repression of Slug by recruiting an SMAR1/HDAC1 complex to the MAR site in the Slug promoter, restoring E-cadherin expression; and (2) blocking E-cadherin-MDM2 interaction, thereby preventing MDM2-mediated ubiquitination and degradation of E-cadherin protein.","method":"ChIP, Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, migration assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — dual mechanism demonstrated with ChIP, Co-IP, ubiquitination assay and loss-of-function; multiple orthogonal methods","pmids":["25086032"],"is_preprint":false},{"year":2015,"finding":"SMAR1 negatively regulates alternative splicing through HDAC6-mediated deacetylation of Sam68. SMAR1 associates with splicing speckles and snRNAs. ERK1/2-mediated phosphorylation of SMAR1 at Thr345 and Thr360 causes its cytoplasmic translocation, releasing the SMAR1-HDAC6-Sam68 inhibitory complex and allowing Sam68 acetylation and alternative splicing (e.g., CD44 variant exon inclusion).","method":"Co-immunoprecipitation, nuclear/cytoplasmic fractionation, CLIP, phosphorylation mapping by mutagenesis, ChIP, alternative splicing assays, in vivo metastasis model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic pathway with in vitro phosphorylation site mapping, CLIP, Co-IP, functional rescue, and in vivo validation","pmids":["26080397"],"is_preprint":false},{"year":2014,"finding":"SMAR1 coordinates HDAC6-mediated deacetylation of Ku70, maintaining Ku70 in a deacetylated state that allows its association with Bax and suppression of Bax mitochondrial translocation (providing radioresistance). Ionizing radiation induces SMAR1 expression and ATM-mediated phosphorylation at Ser370, redistributing SMAR1 to nuclear foci. SMAR1 also facilitates Chk2 phosphorylation to enforce G2/M arrest.","method":"Co-immunoprecipitation, chromatin fractionation, acetylation assays, siRNA knockdown, phospho-mutant analysis, irradiation experiments","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — multiple Co-IPs and functional assays; single lab","pmids":["25299772"],"is_preprint":false},{"year":2017,"finding":"Cdc20, a substrate receptor of the APC/C ubiquitin ligase complex, binds SMAR1 via its D-box motif and promotes K48-linked polyubiquitylation and proteasomal degradation of SMAR1. shRNA-mediated knockdown of Cdc20 stabilizes SMAR1. Genotoxic stress prevents Cdc20-mediated SMAR1 degradation.","method":"Co-immunoprecipitation, ubiquitination assay (K48-specific), shRNA knockdown, D-box mutant analysis, proteasome inhibitor experiments","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — polyubiquitylation linkage specificity shown, D-box mutant used, multiple E3 ligases screened, reciprocal Co-IP; well-controlled mechanistic study","pmids":["28617439"],"is_preprint":false},{"year":2008,"finding":"SMAR1 binds directly to a MAR site in the IκBα promoter and recruits a corepressor complex to repress IκBα transcription. SMAR1 also inhibits p65 transactivation by producing phosphorylation-deficient NF-κB complexes, downregulating a subset of tumorigenic NF-κB target genes.","method":"ChIP, reporter assays, Co-immunoprecipitation, NF-κB target gene array","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and reporter assays with mechanistic pathway dissection; single lab","pmids":["18981184"],"is_preprint":false},{"year":2021,"finding":"SMAR1 regulates PKM alternative splicing by recruiting HDAC6 to deacetylate PTBP1, reducing PTBP1 enrichment on PKM pre-mRNA, thereby suppressing PKM2 isoform expression and inhibiting the Warburg effect in cancer cells.","method":"Co-immunoprecipitation, CLIP, acetylation assays, qRT-PCR, enzymatic glycolysis assays, in vivo tumor assay","journal":"Cancer & metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — CLIP demonstrated direct pre-mRNA association, multiple biochemical assays; single lab","pmids":["33863392"],"is_preprint":false},{"year":2015,"finding":"SMAR1 negatively regulates STAT3 expression by binding to the MAR element of the STAT3 promoter, adjacent to IL-6 response elements, favoring Foxp3 expression and regulatory T cell differentiation over Th17 differentiation in the context of inflammatory bowel disease.","method":"ChIP, T cell-specific conditional SMAR1 knockout mice, colitis models, cytokine assays","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and in vivo conditional knockout with defined immunological phenotype; single lab","pmids":["25993445"],"is_preprint":false},{"year":2015,"finding":"SMAR1 functions as a negative regulator of Th1 and Th17 differentiation by recruiting the HDAC1-SMRT complex to MAR regions on the T-bet and IL-17 promoters, thereby repressing their transcription and promoting Th2 cell establishment in the context of allergic airway disease.","method":"ChIP, T cell-specific conditional SMAR1 knockout mice, airway inflammation model, cytokine assays","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and conditional KO with defined in vivo phenotype; single lab","pmids":["25736456"],"is_preprint":false},{"year":2018,"finding":"SMAR1 inhibits Wnt/β-catenin signaling by recruiting HDAC5 to the β-catenin promoter, reducing its transcription. SMAR1 is itself degraded via its D-box elements ('RCHL' and 'RQRL') in response to aberrant Wnt3a signaling; substitution mutations in these D-box elements completely abrogate proteasomal degradation.","method":"ChIP, reporter assays, mutagenesis of D-box elements, isothermal titration calorimetry, in vivo tumor assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP, D-box mutagenesis, ITC, in vivo validation; single lab","pmids":["29765542"],"is_preprint":false},{"year":2007,"finding":"SMAR1 mRNA is stabilized by Prostaglandin A2 (PGA2) through a stem-loop structure in its 5' UTR (the '1-UTR' form). This stabilization leads to increased SMAR1 protein and subsequent downregulation of Cyclin D1. Breast cancer cell lines harbor a variant 5' UTR ('17-UTR') lacking this stem-loop, making SMAR1 mRNA non-responsive to PGA2 stabilization.","method":"RNA EMSA, 5' UTR deletion/mutation constructs, reporter assays, RT-PCR quantification","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — RNA structural element functionally mapped by mutagenesis; single lab","pmids":["17726044"],"is_preprint":false},{"year":2010,"finding":"HSP70 binds to a novel site in the 5' UTR of SMAR1 (the phi1 form) upon PGA2 treatment, stabilizing the wild-type SMAR1 transcript and increasing protein levels, contributing to PGA2-mediated cell cycle arrest. HSP70 cannot bind the phi17 variant 5' UTR present in breast cancer cells.","method":"RNA pulldown/RIP assays, HSP70 knockdown, mRNA stability assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct RNA-protein interaction demonstrated; mechanistic consequence shown by knockdown; single lab","pmids":["20153327"],"is_preprint":false},{"year":2009,"finding":"TNFα stimulation induces phosphorylation of SMAR1 at Ser-347, promoting its cytoplasmic translocation and releasing its negative regulation of CD40 transcription. Simultaneously, TNFα-induced JAK1-mediated phosphorylation of STAT1 at Tyr-701 enables STAT1 nuclear translocation and CD40 activation via p300 recruitment and histone H3 acetylation.","method":"Phospho-specific detection, subcellular fractionation, ChIP, reporter assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — phosphorylation-dependent localization change mechanistically linked to target gene regulation; single lab","pmids":["20006573"],"is_preprint":false},{"year":2024,"finding":"BANP promotes p53 phosphorylation and nuclear retention in vascular endothelial cells exposed to chronic intermittent hypoxia, inducing cellular senescence. BANP overexpression alone was sufficient to induce senescence.","method":"BANP overexpression in HUVECs, EdU assay, cell cycle analysis, SA-β-gal staining, Western blot for p53/p21, in vivo CIH rat model","journal":"Gerontology","confidence":"Low","confidence_rationale":"Tier 3 — gain-of-function with phenotypic readout but limited mechanistic dissection of BANP-p53 interaction; single lab","pmids":["38168028"],"is_preprint":false},{"year":2024,"finding":"ZNF471 interacts with BANP in renal cell carcinoma cells and suppresses the PI3K/AKT/mTOR signaling pathway to inhibit cancer malignancy.","method":"Co-immunoprecipitation, signaling pathway analysis, functional cell biology assays","journal":"International journal of biological sciences","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP, pathway placement based on inhibitor/western blot; limited mechanistic detail","pmids":["38169650"],"is_preprint":false},{"year":2011,"finding":"SMAR1 inhibits p53 acetylation and p53-dependent apoptosis by repressing p300 expression and by interacting with the p53-p300 transcriptional complex to antagonize p300-p53 interaction, thereby suppressing activation of p53 apoptotic targets and miR-34a.","method":"Co-immunoprecipitation, reporter assays, siRNA knockdown, Western blot","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — mechanistic dissection by Co-IP and functional rescue; single lab","pmids":["22074660"],"is_preprint":false},{"year":2020,"finding":"SMAR1 expression in breast cancer stem cells is repressed by cooperative interaction of pluripotency factors Oct4 and Sox2 with HDAC1 at the SMAR1 promoter. Conversely, SMAR1 suppresses ABCG2 transcription by recruiting HDAC2 to the ABCG2 promoter, sensitizing cancer stem cells to chemotherapy.","method":"ChIP, Co-immunoprecipitation, reporter assays, shRNA, in vivo tumor model","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and Co-IP with functional in vivo validation; single lab","pmids":["33082288"],"is_preprint":false}],"current_model":"BANP/SMAR1 is a BEN domain-containing transcription factor and nuclear matrix-associated protein that binds unmethylated CGCG motifs (Banp motif) at CpG island promoters—a process structurally dependent on BEN domain oligomerization—to open chromatin, phase nucleosomes, and activate essential metabolic and cell-cycle genes; its binding is epigenetically gated by CpG methylation. BANP also functions as a transcriptional repressor by recruiting HDAC1/SIN3, HDAC6, or HDAC5 corepressor complexes to MAR elements at target promoters (cyclin D1, Slug, β-catenin, STAT3, IκBα, among others), and it stabilizes and activates p53 through direct interaction via its RS domain while blocking MDM2-mediated degradation; it additionally modulates alternative splicing by maintaining Sam68 and PTBP1 in a deacetylated state via HDAC6, and is itself subject to proteasomal degradation via APC/C-Cdc20-mediated K48-linked polyubiquitylation at its D-box motifs."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of BANP as a MAR-binding nuclear protein at the TCRβ locus established its fundamental DNA-binding specificity for scaffold/matrix-associated regions, providing the initial molecular handle for subsequent functional studies.","evidence":"EMSA and GST-pulldown with MARβ DNA, RT-PCR for tissue expression, and chromosomal mapping in mouse","pmids":["10950932"],"confidence":"Medium","gaps":["MAR-binding specificity shown by competition only, without genome-wide binding data","functional consequence of MAR binding at TCRβ not yet demonstrated"]},{"year":2003,"claim":"Demonstration that BANP physically interacts with p53 and activates p53-dependent transcription linked this MAR-binding protein to the central tumor suppressor pathway, explaining its anti-proliferative activity.","evidence":"Co-immunoprecipitation, reporter assays, cell cycle analysis, and in vivo tumor growth delay upon SMAR1(S) overexpression","pmids":["12494467"],"confidence":"Medium","gaps":["domain of interaction with p53 not yet mapped","mechanism of p53 stabilization unknown"]},{"year":2005,"claim":"Mapping of the RS domain as the p53-interaction and stabilization interface, and identification of PKC-mediated phosphorylation at Ser347 as essential for this activity, defined the molecular basis of BANP-p53 signaling and revealed that BANP blocks MDM2-mediated p53 degradation.","evidence":"Domain deletion/mutagenesis, in vitro kinase assays, Co-IP, siRNA, and SMAR1 transgenic mice","pmids":["15701641"],"confidence":"High","gaps":["structural basis of RS domain–p53 interaction not resolved","whether PKC isoform selectivity matters in vivo is untested"]},{"year":2005,"claim":"Discovery that BANP represses cyclin D1 by recruiting the SIN3/HDAC1 complex to its promoter MAR element established the paradigm of BANP as an HDAC-dependent transcriptional repressor acting through MAR sites.","evidence":"ChIP, Co-IP, reporter assays, siRNA knockdown showing HDAC1 recruitment and histone deacetylation spreading over 5 kb","pmids":["16166625"],"confidence":"High","gaps":["whether BANP recruits additional corepressor subunits besides SIN3/HDAC1 at this locus was unknown","genome-wide extent of MAR-dependent repression not mapped"]},{"year":2008,"claim":"Extension of the MAR-dependent repression model to the IκBα promoter and demonstration that BANP inhibits NF-κB transactivation broadened its role to inflammatory signaling regulation.","evidence":"ChIP at the IκBα MAR site, reporter assays, NF-κB target gene array","pmids":["18981184"],"confidence":"Medium","gaps":["identity of the corepressor complex at the IκBα promoter not specified","not confirmed in primary immune cells"]},{"year":2009,"claim":"Identification of a ternary BANP–MDM2–phospho-p53 complex that recruits HDAC1 to deacetylate p53 during post-stress recovery revealed that BANP acts as a molecular switch to terminate the p53 response, resolving the paradox of how BANP both activates and attenuates p53.","evidence":"Co-IP of ternary complex, ChIP at p21 promoter, cell cycle kinetics after stress recovery","pmids":["19303885"],"confidence":"Medium","gaps":["temporal dynamics of complex assembly not quantified","whether this switch operates in non-transformed cells in vivo is untested"]},{"year":2010,"claim":"The finding that severe DNA damage sequesters BANP into PML nuclear bodies—releasing its repression of BAX/PUMA—provided a mechanism for how damage severity is decoded to choose between cell-cycle arrest and apoptosis.","evidence":"ChIP, PML body imaging, reporter assays, SMAR1 mutant analysis in cells with graded DNA damage","pmids":["20075864"],"confidence":"High","gaps":["signals controlling PML body sequestration of BANP not identified","whether this mechanism operates in vivo tissue homeostasis is unknown"]},{"year":2014,"claim":"Demonstration that BANP inhibits EMT by both transcriptionally repressing Slug via HDAC1 and stabilizing E-cadherin protein by blocking MDM2-mediated ubiquitination revealed a dual-level anti-metastatic mechanism.","evidence":"ChIP at Slug promoter MAR, Co-IP, ubiquitination assay, migration assay in breast cancer cells","pmids":["25086032"],"confidence":"High","gaps":["whether BANP directly contacts MDM2 at E-cadherin or acts indirectly is unresolved","in vivo metastasis suppression via this dual mechanism not shown"]},{"year":2015,"claim":"Discovery that BANP regulates alternative splicing by maintaining Sam68 in a deacetylated state via HDAC6, with ERK1/2-mediated phosphorylation of BANP causing cytoplasmic translocation and release of splicing regulation, established a non-transcriptional function and a signaling-dependent toggle mechanism.","evidence":"Co-IP, CLIP, phosphorylation site mutagenesis, alternative splicing assays for CD44, in vivo metastasis model","pmids":["26080397"],"confidence":"High","gaps":["full repertoire of BANP-regulated alternative splicing events not catalogued","direct structural basis of BANP–Sam68 interaction unknown"]},{"year":2015,"claim":"Conditional T cell-specific BANP knockout revealed its role in repressing Th1/Th17 differentiation by recruiting HDAC1-SMRT to T-bet/IL-17 promoters and in repressing STAT3 to favor Foxp3+ Treg differentiation, establishing BANP as a key regulator of T helper cell fate.","evidence":"ChIP at T-bet, IL-17, and STAT3 promoters; conditional KO mice in colitis and airway inflammation models","pmids":["25993445","25736456"],"confidence":"Medium","gaps":["whether BANP binds MAR or CGCG motifs at these immune gene promoters is not distinguished","human immunological relevance not confirmed"]},{"year":2017,"claim":"Identification of APC/C–Cdc20 as the E3 ligase that targets BANP for K48-linked polyubiquitylation via D-box motifs explained how BANP protein levels are dynamically controlled, with genotoxic stress blocking this degradation to stabilize BANP.","evidence":"Co-IP, K48-specific ubiquitination assay, D-box mutant analysis, proteasome inhibitor experiments, shRNA of Cdc20","pmids":["28617439"],"confidence":"High","gaps":["cell-cycle phase dependence of APC/C–Cdc20-mediated BANP turnover not determined","whether D-box degradation interfaces with the Wnt-induced degradation pathway is unclear"]},{"year":2021,"claim":"Genome-wide identification of BANP as the transcription factor for the CGCG (Banp) motif at CpG island promoters, with methylation-gated binding leading to chromatin opening and activation of essential metabolic genes, fundamentally reframed BANP from a MAR-binding repressor to a dual-function activator/repressor whose binding is epigenetically regulated.","evidence":"Single-molecule footprinting, interaction proteomics, ChIP-seq, in vitro binding with methylated/unmethylated substrates in mouse ES cells and neurons","pmids":["34234345"],"confidence":"High","gaps":["how BANP activation at CpG islands and repression at MARs are coordinated genome-wide is unresolved","whether BANP is essential in adult tissues beyond development unknown"]},{"year":2022,"claim":"Zebrafish genetic studies demonstrated that Banp directly activates DNA replication and chromosome segregation genes (wrnip1, cenpt, ncapg) via the Banp motif, and its loss triggers replication stress, p53-dependent apoptosis, and prolonged M-phase, validating the essential in vivo role predicted by the CpG island activation model.","evidence":"banp mutant and morphant zebrafish, RNA-seq, ATAC-seq, epistasis with tp53","pmids":["35942692"],"confidence":"High","gaps":["mammalian in vivo validation of these specific target genes is lacking","whether Banp loss phenotypes are fully p53-dependent is unclear"]},{"year":2023,"claim":"Crystal structures of the BANP BEN domain in apo and DNA-bound forms revealed electrostatic DNA contacts with base-specific recognition at TC motifs, but showed comparable affinity for methylated and unmethylated DNA by the isolated domain, creating a mechanistic puzzle about methylation selectivity.","evidence":"X-ray crystallography, ITC, protein binding microarray, site-directed mutagenesis","pmids":["37086783"],"confidence":"High","gaps":["discrepancy between isolated domain and full-length protein methylation sensitivity unresolved at this point"]},{"year":2024,"claim":"Follow-up crystal structures resolved the methylation-selectivity puzzle by showing that BEN domain oligomerization is required for preferential binding of unmethylated CGCG substrates, establishing the structural basis for BANP's role as a CpG island-specific transcription factor.","evidence":"X-ray crystallography of BEN domain–DNA complexes with oligomerization analysis","pmids":["39225042"],"confidence":"High","gaps":["full-length BANP structure not determined","oligomeric state in vivo not confirmed","how oligomerization interfaces with chromatin context is unknown"]},{"year":null,"claim":"Key unresolved questions include how BANP's dual roles as a CpG island activator and MAR-dependent repressor are coordinated at the genome-wide level, what determines target selection between these two modes, and whether BANP is essential in adult mammalian tissues.","evidence":"","pmids":[],"confidence":"High","gaps":["no genome-wide integration of activator and repressor binding profiles","no conditional knockout phenotype in adult mammals","no full-length BANP structure or structural model of BANP bound to MAR DNA"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,4,7,11,12,19,21,22]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,7,11,15,21,22,23,30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6,7,8,11,16,17]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,3,7,15,21,22,23,30]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,7,11,12]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3,6,7,17]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,17]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[16,20]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[18]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21,22]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[19,23]}],"complexes":["SIN3/HDAC1 corepressor complex","SMAR1-HDAC6-Sam68 complex","SMAR1-MDM2-p53 ternary complex"],"partners":["TP53","MDM2","HDAC1","HDAC6","HDAC5","KHDRBS1","CDC20","PTBP1"],"other_free_text":[]},"mechanistic_narrative":"BANP (also known as SMAR1) is a BEN domain-containing transcription factor that functions as both a sequence-specific activator at unmethylated CpG island promoters and an HDAC-dependent repressor at MAR elements, thereby coordinating essential metabolic gene expression, cell-cycle control, p53 signaling, alternative splicing, and T helper cell differentiation. BANP binds unmethylated CGCG motifs at CpG island promoters through its BEN domain, where oligomerization is required for methylation-sensitive substrate selection, leading to chromatin opening, nucleosome phasing, and activation of essential metabolic and DNA replication genes [PMID:34234345, PMID:39225042, PMID:35942692]. At MAR elements, BANP recruits HDAC1/SIN3, HDAC5, or HDAC6 corepressor complexes to repress target promoters including cyclin D1, Slug, β-catenin, STAT3, IκBα, and T-bet, and it modulates alternative splicing of CD44 and PKM pre-mRNAs by maintaining the splicing regulators Sam68 and PTBP1 in a deacetylated state via HDAC6 [PMID:16166625, PMID:25086032, PMID:26080397, PMID:33863392, PMID:25993445]. BANP stabilizes and activates p53 through direct interaction via its RS domain while blocking MDM2-mediated degradation, and during post-stress recovery it participates in a ternary complex with MDM2 and phospho-p53 that recruits HDAC1 to deacetylate p53 and terminate the stress response; BANP itself is subject to APC/C–Cdc20-mediated K48-linked polyubiquitylation and proteasomal degradation [PMID:15701641, PMID:19303885, PMID:28617439]."},"prefetch_data":{"uniprot":{"accession":"Q8N9N5","full_name":"Protein BANP","aliases":["BEN domain-containing protein 1","Btg3-associated nuclear protein","Scaffold/matrix-associated region-1-binding protein"],"length_aa":519,"mass_kda":56.5,"function":"Controls V(D)J recombination during T-cell development by repressing T-cell receptor (TCR) beta enhancer function (By similarity). Binds to scaffold/matrix attachment region beta (S/MARbeta), an ATC-rich DNA sequence located upstream of the TCR beta enhancer (By similarity). Represses cyclin D1 transcription by recruiting HDAC1 to its promoter, thereby diminishing H3K9ac, H3S10ph and H4K8ac levels (PubMed:16166625). Promotes TP53 activation, which causes cell cycle arrest (By similarity). Plays a role in the regulation of alternative splicing (PubMed:26080397). Binds to CD44 pre-mRNA and negatively regulates the inclusion of CD44 proximal variable exons v2-v6 but has no effect on distal variable exons v7-v10 (PubMed:26080397)","subcellular_location":"Nucleus; Nucleus speckle; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q8N9N5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/BANP","classification":"Common Essential","n_dependent_lines":1157,"n_total_lines":1208,"dependency_fraction":0.9577814569536424},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BANP","total_profiled":1310},"omim":[{"mim_id":"611564","title":"BTG3-ASSOCIATED NUCLEAR PROTEIN; BANP","url":"https://www.omim.org/entry/611564"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BANP"},"hgnc":{"alias_symbol":["SMARBP1","SMAR1","FLJ20538","DKFZp761H172","FLJ10177","BEND1"],"prev_symbol":[]},"alphafold":{"accession":"Q8N9N5","domains":[{"cath_id":"1.10.10.2590","chopping":"198-327","consensus_level":"medium","plddt":88.5757,"start":198,"end":327},{"cath_id":"-","chopping":"394-458","consensus_level":"medium","plddt":46.0505,"start":394,"end":458}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N9N5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N9N5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N9N5-F1-predicted_aligned_error_v6.png","plddt_mean":53.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BANP","jax_strain_url":"https://www.jax.org/strain/search?query=BANP"},"sequence":{"accession":"Q8N9N5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N9N5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N9N5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N9N5"}},"corpus_meta":[{"pmid":"28103507","id":"PMC_28103507","title":"Circular BANP, an upregulated circular RNA that modulates cell proliferation in colorectal cancer.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28103507","citation_count":145,"is_preprint":false},{"pmid":"16166625","id":"PMC_16166625","title":"Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16166625","citation_count":98,"is_preprint":false},{"pmid":"29969631","id":"PMC_29969631","title":"CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29969631","citation_count":82,"is_preprint":false},{"pmid":"25086032","id":"PMC_25086032","title":"Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25086032","citation_count":81,"is_preprint":false},{"pmid":"34234345","id":"PMC_34234345","title":"BANP opens chromatin and activates CpG-island-regulated genes.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34234345","citation_count":71,"is_preprint":false},{"pmid":"12494467","id":"PMC_12494467","title":"Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.","date":"2003","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12494467","citation_count":69,"is_preprint":false},{"pmid":"20075864","id":"PMC_20075864","title":"Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20075864","citation_count":55,"is_preprint":false},{"pmid":"24926985","id":"PMC_24926985","title":"Capsaicin-induced activation of p53-SMAR1 auto-regulatory loop down-regulates VEGF in non-small cell lung cancer to restrain angiogenesis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24926985","citation_count":54,"is_preprint":false},{"pmid":"17668048","id":"PMC_17668048","title":"p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17668048","citation_count":54,"is_preprint":false},{"pmid":"10950932","id":"PMC_10950932","title":"SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/Matrix-associated region at the T cell receptor beta locus.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10950932","citation_count":52,"is_preprint":false},{"pmid":"28617439","id":"PMC_28617439","title":"Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28617439","citation_count":50,"is_preprint":false},{"pmid":"22674979","id":"PMC_22674979","title":"Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, β-catenin, and SMAR1 to repress HIV transcription.","date":"2012","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/22674979","citation_count":47,"is_preprint":false},{"pmid":"19799771","id":"PMC_19799771","title":"Tumor suppressor protein SMAR1 modulates the roughness of cell surface: combined AFM and SEM study.","date":"2009","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19799771","citation_count":47,"is_preprint":false},{"pmid":"26080397","id":"PMC_26080397","title":"Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26080397","citation_count":43,"is_preprint":false},{"pmid":"15371550","id":"PMC_15371550","title":"SMAR1 and Cux/CDP modulate chromatin and act as negative regulators of the TCRbeta enhancer (Ebeta).","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15371550","citation_count":36,"is_preprint":false},{"pmid":"20709157","id":"PMC_20709157","title":"Gene regulation by SMAR1: Role in cellular homeostasis and cancer.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20709157","citation_count":34,"is_preprint":false},{"pmid":"15701641","id":"PMC_15701641","title":"Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15701641","citation_count":31,"is_preprint":false},{"pmid":"25157104","id":"PMC_25157104","title":"Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25157104","citation_count":29,"is_preprint":false},{"pmid":"20153010","id":"PMC_20153010","title":"Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling.","date":"2010","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/20153010","citation_count":27,"is_preprint":false},{"pmid":"33863392","id":"PMC_33863392","title":"Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1.","date":"2021","source":"Cancer & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33863392","citation_count":26,"is_preprint":false},{"pmid":"17229733","id":"PMC_17229733","title":"SMAR1-derived P44 peptide retains its tumor suppressor function through modulation of p53.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17229733","citation_count":26,"is_preprint":false},{"pmid":"19303885","id":"PMC_19303885","title":"SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19303885","citation_count":25,"is_preprint":false},{"pmid":"25299772","id":"PMC_25299772","title":"SMAR1 coordinates HDAC6-induced deacetylation of Ku70 and dictates cell fate upon irradiation.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25299772","citation_count":23,"is_preprint":false},{"pmid":"33082288","id":"PMC_33082288","title":"SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin.","date":"2020","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/33082288","citation_count":23,"is_preprint":false},{"pmid":"29765542","id":"PMC_29765542","title":"SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29765542","citation_count":23,"is_preprint":false},{"pmid":"15623522","id":"PMC_15623522","title":"Abnormal V(D)J recombination of T cell receptor beta locus in SMAR1 transgenic mice.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15623522","citation_count":22,"is_preprint":false},{"pmid":"33298736","id":"PMC_33298736","title":"Circular RNA Circ-BANP Regulates Oxidized Low-density Lipoprotein-induced Endothelial Cell Injury Through Targeting the miR-370/Thioredoxin-interacting Protein Axis.","date":"2021","source":"Journal of cardiovascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33298736","citation_count":22,"is_preprint":false},{"pmid":"18981184","id":"PMC_18981184","title":"Tumor suppressor SMAR1 represses IkappaBalpha expression and inhibits p65 transactivation through matrix attachment regions.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18981184","citation_count":21,"is_preprint":false},{"pmid":"25993445","id":"PMC_25993445","title":"Nuclear matrix protein SMAR1 control regulatory T-cell fate during inflammatory bowel disease (IBD).","date":"2015","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25993445","citation_count":20,"is_preprint":false},{"pmid":"23876508","id":"PMC_23876508","title":"miR-320a regulates erythroid differentiation through MAR binding protein SMAR1.","date":"2013","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23876508","citation_count":20,"is_preprint":false},{"pmid":"10940556","id":"PMC_10940556","title":"Identification and molecular analysis of BANP.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10940556","citation_count":18,"is_preprint":false},{"pmid":"25736456","id":"PMC_25736456","title":"Nuclear matrix binding protein SMAR1 regulates T-cell differentiation and allergic airway disease.","date":"2015","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25736456","citation_count":16,"is_preprint":false},{"pmid":"31422285","id":"PMC_31422285","title":"SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.","date":"2019","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31422285","citation_count":15,"is_preprint":false},{"pmid":"35942692","id":"PMC_35942692","title":"Banp regulates DNA damage response and chromosome segregation during the cell cycle in zebrafish retina.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35942692","citation_count":15,"is_preprint":false},{"pmid":"22978699","id":"PMC_22978699","title":"Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment.","date":"2012","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22978699","citation_count":13,"is_preprint":false},{"pmid":"27934984","id":"PMC_27934984","title":"Control of apoptosis by SMAR1.","date":"2017","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/27934984","citation_count":13,"is_preprint":false},{"pmid":"22074660","id":"PMC_22074660","title":"Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.","date":"2011","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22074660","citation_count":13,"is_preprint":false},{"pmid":"20097305","id":"PMC_20097305","title":"SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity.","date":"2010","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20097305","citation_count":13,"is_preprint":false},{"pmid":"36810109","id":"PMC_36810109","title":"RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/36810109","citation_count":13,"is_preprint":false},{"pmid":"27671416","id":"PMC_27671416","title":"SMAR1 binds to T(C/G) repeat and inhibits tumor progression by regulating miR-371-373 cluster.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27671416","citation_count":12,"is_preprint":false},{"pmid":"17726044","id":"PMC_17726044","title":"Stabilization of SMAR1 mRNA by PGA2 involves a stem loop structure in the 5' UTR.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17726044","citation_count":12,"is_preprint":false},{"pmid":"18822384","id":"PMC_18822384","title":"Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.","date":"2008","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18822384","citation_count":11,"is_preprint":false},{"pmid":"20153327","id":"PMC_20153327","title":"Heat-shock protein 70 binds to a novel sequence in 5' UTR of tumor suppressor SMAR1 and regulates its mRNA stability upon Prostaglandin A2 treatment.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20153327","citation_count":11,"is_preprint":false},{"pmid":"26629941","id":"PMC_26629941","title":"Overexpression of SMAR1 Enhances Radiosensitivity in Human Breast Cancer Cell Line MCF7 via Activation of p53 Signaling Pathway.","date":"2014","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/26629941","citation_count":10,"is_preprint":false},{"pmid":"28232831","id":"PMC_28232831","title":"Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases.","date":"2017","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28232831","citation_count":10,"is_preprint":false},{"pmid":"38169650","id":"PMC_38169650","title":"ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38169650","citation_count":9,"is_preprint":false},{"pmid":"34985013","id":"PMC_34985013","title":"Circular BANP knockdown inhibits the malignant progression of residual hepatocellular carcinoma after insufficient radiofrequency ablation.","date":"2022","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/34985013","citation_count":9,"is_preprint":false},{"pmid":"39240540","id":"PMC_39240540","title":"SMAR1 and p53-regulated lncRNA RP11-431M3.1 enhances HIF1A translation via miR-138 in colorectal cancer cells under oxidative stress.","date":"2024","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/39240540","citation_count":9,"is_preprint":false},{"pmid":"37086783","id":"PMC_37086783","title":"Structural insights into DNA recognition by the BEN domain of the transcription factor BANP.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37086783","citation_count":8,"is_preprint":false},{"pmid":"35980125","id":"PMC_35980125","title":"SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/β-catenin signaling pathway.","date":"2022","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/35980125","citation_count":8,"is_preprint":false},{"pmid":"25239884","id":"PMC_25239884","title":"Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.","date":"2014","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25239884","citation_count":8,"is_preprint":false},{"pmid":"27274234","id":"PMC_27274234","title":"Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.","date":"2016","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/27274234","citation_count":8,"is_preprint":false},{"pmid":"26168735","id":"PMC_26168735","title":"MAR binding protein SMAR1 favors IL-10 mediated regulatory T cell function in acute colitis.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26168735","citation_count":7,"is_preprint":false},{"pmid":"33543840","id":"PMC_33543840","title":"SMAR1 attenuates the stemness of osteosarcoma cells via through suppressing ABCG2 transcriptional activity.","date":"2021","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33543840","citation_count":7,"is_preprint":false},{"pmid":"20006573","id":"PMC_20006573","title":"Tumor Necrosis Factor alpha (TNFalpha) regulates CD40 expression through SMAR1 phosphorylation.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20006573","citation_count":6,"is_preprint":false},{"pmid":"36505804","id":"PMC_36505804","title":"The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36505804","citation_count":6,"is_preprint":false},{"pmid":"34689394","id":"PMC_34689394","title":"RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4-TRIF pathway.","date":"2022","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34689394","citation_count":6,"is_preprint":false},{"pmid":"34450266","id":"PMC_34450266","title":"Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ.","date":"2021","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/34450266","citation_count":5,"is_preprint":false},{"pmid":"38168028","id":"PMC_38168028","title":"BANP Participates in the Chronic Intermittent Hypoxia-Induced Senescence of Vascular Endothelial Cells by Promoting P53 Phosphorylation and Nuclear Retention.","date":"2024","source":"Gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/38168028","citation_count":5,"is_preprint":false},{"pmid":"29338617","id":"PMC_29338617","title":"Carbon nanospheres mediated nuclear delivery of SMAR1 protein (DNA binding domain) controls breast tumor in mice model.","date":"2018","source":"Nanomedicine (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29338617","citation_count":4,"is_preprint":false},{"pmid":"26831422","id":"PMC_26831422","title":"Constitutive expression of SMAR1 confers susceptibility to Mycobacterium tuberculosis infection in a transgenic mouse model.","date":"2015","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26831422","citation_count":2,"is_preprint":false},{"pmid":"26609032","id":"PMC_26609032","title":"Regulation of T cell lineage commitment by SMAR1 during inflammatory & autoimmune diseases.","date":"2015","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26609032","citation_count":2,"is_preprint":false},{"pmid":"39177785","id":"PMC_39177785","title":"Pre-clinical Evaluation of Karanjin Against DMBA-Induced Breast Cancer in Female Sprague-Dawley Rats Through Modulation of SMAR1 and CDP/CUx genes.","date":"2024","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39177785","citation_count":2,"is_preprint":false},{"pmid":"30301506","id":"PMC_30301506","title":"SMAR1 promotes immune escape of Tri-negative Breast Cancer through a mechanism involving T-bet/PD-1 Axis.","date":"2018","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/30301506","citation_count":2,"is_preprint":false},{"pmid":"34551340","id":"PMC_34551340","title":"SMAR1 suppresses the cancer stem cell population via hTERT repression in colorectal cancer cells.","date":"2021","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34551340","citation_count":1,"is_preprint":false},{"pmid":"19802523","id":"PMC_19802523","title":"Modulation of chromatin by MARs and MAR binding oncogenic transcription factor SMAR1.","date":"2009","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19802523","citation_count":1,"is_preprint":false},{"pmid":"39225042","id":"PMC_39225042","title":"Structural basis of DNA recognition by BEN domain proteins reveals a role for oligomerization in unmethylated DNA selection by BANP.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39225042","citation_count":0,"is_preprint":false},{"pmid":"37817309","id":"PMC_37817309","title":"Nuclear Matrix-associated Protein SMAR1 Attenuated Acute Graft-versus-host Disease by Targeting JAK-STAT Signaling in CD4 + T Cells.","date":"2023","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/37817309","citation_count":0,"is_preprint":false},{"pmid":"32807076","id":"PMC_32807076","title":"Correction to: Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment.","date":"2020","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807076","citation_count":0,"is_preprint":false},{"pmid":"27514831","id":"PMC_27514831","title":"Genome-wide association study of copy number variation with lung function identifies a novel signal of association near BANP for forced vital capacity.","date":"2016","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27514831","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34451,"output_tokens":7290,"usd":0.106352},"stage2":{"model":"claude-opus-4-6","input_tokens":11053,"output_tokens":4013,"usd":0.233385},"total_usd":0.339737,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"BANP (SMAR1) is a transcription factor that binds the CGCG element (Banp motif) at CpG island promoters in mouse and human genomes. Upon binding to unmethylated CGCG motifs, BANP opens chromatin and phases nucleosomes, activating essential metabolic genes. DNA methylation of the CGCG motif repels BANP binding in vitro and in vivo, epigenetically restricting binding to CpG islands.\",\n      \"method\": \"Single-molecule footprinting, interaction proteomics, ChIP-seq, in vitro DNA-binding assays with methylated/unmethylated substrates, chromatin accessibility assays in pluripotent and neuronal cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (footprinting, proteomics, ChIP-seq, in vitro binding, functional rescue) in single high-impact study with strong mechanistic validation\",\n      \"pmids\": [\"34234345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Crystal structure of the BANP BEN domain in apo form and in complex with CGCG-containing DNA revealed that BANP mainly uses electrostatic interactions to bind DNA, with base-specific interactions at TC motifs. The optimal DNA-binding sequence is AAATCTCG. Methylated and unmethylated DNAs are bound with comparable affinity by the isolated BEN domain.\",\n      \"method\": \"X-ray crystallography, isothermal titration calorimetry, protein binding microarray, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures of apo and DNA-bound forms, validated by ITC and mutagenesis\",\n      \"pmids\": [\"37086783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Crystal structures of the BANP BEN domain in complex with cognate DNA substrates revealed that oligomerization is required for BANP to select unmethylated CGCG motif-containing DNA substrates, clarifying the mechanism by which BANP functions as a CpG island-binding protein.\",\n      \"method\": \"X-ray crystallography of BEN domain–DNA complexes, biochemical oligomerization assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural determination with functional validation of oligomerization requirement\",\n      \"pmids\": [\"39225042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Zebrafish Banp (ortholog of human BANP) directly regulates transcription of DNA replication fork regulator wrnip1 and chromosome segregation regulators cenpt and ncapg via the Banp motif. Loss of Banp activates DNA replication stress and tp53-dependent DNA damage responses leading to apoptosis, and causes defective chromosome segregation (prolonged M-phase) in developing retina.\",\n      \"method\": \"Zebrafish banp mutants and morphants, RNA-seq, ATAC-seq, identification of Banp-motif-containing target genes, epistasis with tp53\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function in vivo with multiple orthogonal genomic readouts and epistasis analysis\",\n      \"pmids\": [\"35942692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BANP (originally named SMAR1) was identified as a novel MAR-binding protein that binds the MARbeta scaffold/matrix-associated region located upstream of the TCR beta enhancer. GST-SMAR1 fusion protein binding to MARbeta is competed by MAR-containing DNA from the immunoglobulin kappa locus, demonstrating specificity. The gene maps to mouse chromosome 8 (human 16q24) and produces alternatively spliced transcripts most abundant in thymus.\",\n      \"method\": \"EMSA (electrophoretic mobility shift assay), GST pulldown, RT-PCR, chromosomal mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct DNA-binding demonstrated by EMSA and competition assay; single lab study\",\n      \"pmids\": [\"10950932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"BANP was identified as a BTG3-associated nuclear protein through a yeast two-hybrid screen using BTG3 as bait, and was localized to human chromosome 16q24, a region showing frequent loss of heterozygosity in tumors.\",\n      \"method\": \"Yeast two-hybrid screen, chromosomal localization\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid only; other protein-binding assays did not confirm the interaction\",\n      \"pmids\": [\"10940556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SMAR1 (BANP) physically interacts with and colocalizes with p53, and overexpression of the short isoform SMAR1(S) activates p53-mediated reporter gene expression and its downstream effector p21, causing G2/M cell-cycle arrest and delaying tumor growth in vivo.\",\n      \"method\": \"Co-immunoprecipitation, colocalization, reporter gene assays, cell cycle analysis, in vivo tumor growth assay\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and functional readouts in multiple cell lines and in vivo, single lab\",\n      \"pmids\": [\"12494467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SMAR1 (BANP) represses cyclin D1 gene expression by recruiting the SIN3/HDAC1 complex and pocket retinoblastoma proteins to the cyclin D1 promoter MAR element, causing chromatin deacetylation spreading at least 5 kb upstream. The interaction is mediated by SMAR1 domain aa 160-350.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain mapping, ChIP, Co-IP, functional reporter assays provide multiple orthogonal lines of evidence\",\n      \"pmids\": [\"16166625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The arginine-serine-rich (RS) domain of SMAR1 (BANP) is phosphorylated by protein kinase C family proteins and is the minimal domain responsible for interaction with, activation, and nuclear stabilization of p53. SMAR1 stabilizes p53 by inhibiting MDM2-mediated degradation. Serine 347 of SMAR1 is the PKC phosphorylation site indispensable for its activity.\",\n      \"method\": \"Domain deletion/mutagenesis, in vitro phosphorylation assays, co-immunoprecipitation, siRNA knockdown, SMAR1 transgenic mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro phosphorylation, mutagenesis of active site, Co-IP, in vivo transgenic validation\",\n      \"pmids\": [\"15701641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SMAR1 and Cux/CDP modulate chromatin structure at the MARbeta region (by DNaseI hypersensitivity) and independently repress TCRbeta enhancer-dependent transcription. SMAR1 and Cux physically interact and colocalize in the perinuclear region; repression is enhanced by their co-expression. The repression domain of SMAR1 is distinct from its MAR-binding domain and contains an NLS and RS-rich domain.\",\n      \"method\": \"DNaseI hypersensitivity, reporter assays, Co-immunoprecipitation, colocalization imaging, domain mapping\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (chromatin accessibility, Co-IP, reporter assays, domain dissection), single lab\",\n      \"pmids\": [\"15371550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SMAR1 forms a ternary complex with MDM2 and Ser15-phosphorylated p53 in the post-stress recovery phase. This complex recruits HDAC1 to deacetylate p53, causing p53 to bind poorly to target promoters (e.g., p21), switching off the p53 response to allow cell cycle re-entry. SMAR1 knockdown prolongs cell-cycle arrest post-stress.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ternary complex identified by Co-IP, functional consequence demonstrated by ChIP and cell cycle assays; single lab\",\n      \"pmids\": [\"19303885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SMAR1 represses BAX and PUMA promoters by binding to an identical MAR element present in both promoters, independently of p53. On mild DNA damage, SMAR1 selectively represses these pro-apoptotic genes via HDAC1-mediated p53 deacetylation, generating cell cycle arrest instead of apoptosis. On severe DNA damage, SMAR1 is sequestered by enlarged PML nuclear bodies, releasing SMAR1 binding and allowing p53 acetylation and apoptosis.\",\n      \"method\": \"ChIP, reporter assays, Co-IP, siRNA knockdown, PML body imaging, SMAR1 mutant analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, mechanistic switch demonstrated with pathway epistasis; published in high-impact journal\",\n      \"pmids\": [\"20075864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SMAR1 binds to the HIV-1 LTR MAR element and recruits the HDAC1-mSin3 corepressor complex, tethering the LTR to the nuclear matrix and silencing HIV transcription. Cellular activation by PMA/TNFα dislodges the corepressor, increases histone acetylation, reduces trimethylation, and enables RNA Pol II recruitment.\",\n      \"method\": \"ChIP, reporter assays, corepressor complex Co-IP, nuclear matrix fractionation, virion production assay\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and functional readouts with mechanistic dissection; single lab\",\n      \"pmids\": [\"20153010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SMAR1 directly interacts with and inhibits AKR1a4 enzyme activity in the cytoplasm. Upon stress, ATM kinase triggers nuclear translocation of SMAR1, which dissociates the SMAR1-AKR1a4 complex and elevates AKR1a4 activity for free radical scavenging.\",\n      \"method\": \"Co-immunoprecipitation, enzyme activity assay, subcellular fractionation, ATM inhibitor experiments\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct enzyme inhibition demonstrated biochemically, localization by fractionation; single lab\",\n      \"pmids\": [\"20097305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TCF-4, β-catenin, and SMAR1 form a complex that tethers the HIV LTR at the -143 nt site, repressing basal HIV promoter activity. Deletion/mutation of this site or knockdown of TCF-4/β-catenin increases basal LTR activity ~5-fold but does not affect Tat-mediated transactivation.\",\n      \"method\": \"ChIP, luciferase reporter assays, siRNA knockdown, mutant LTR constructs\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and reporter assays with mutational dissection; single lab\",\n      \"pmids\": [\"22674979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SMAR1 inhibits EMT in breast cancer cells via two mechanisms: (1) transcriptional repression of Slug by recruiting an SMAR1/HDAC1 complex to the MAR site in the Slug promoter, restoring E-cadherin expression; and (2) blocking E-cadherin-MDM2 interaction, thereby preventing MDM2-mediated ubiquitination and degradation of E-cadherin protein.\",\n      \"method\": \"ChIP, Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, migration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — dual mechanism demonstrated with ChIP, Co-IP, ubiquitination assay and loss-of-function; multiple orthogonal methods\",\n      \"pmids\": [\"25086032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SMAR1 negatively regulates alternative splicing through HDAC6-mediated deacetylation of Sam68. SMAR1 associates with splicing speckles and snRNAs. ERK1/2-mediated phosphorylation of SMAR1 at Thr345 and Thr360 causes its cytoplasmic translocation, releasing the SMAR1-HDAC6-Sam68 inhibitory complex and allowing Sam68 acetylation and alternative splicing (e.g., CD44 variant exon inclusion).\",\n      \"method\": \"Co-immunoprecipitation, nuclear/cytoplasmic fractionation, CLIP, phosphorylation mapping by mutagenesis, ChIP, alternative splicing assays, in vivo metastasis model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic pathway with in vitro phosphorylation site mapping, CLIP, Co-IP, functional rescue, and in vivo validation\",\n      \"pmids\": [\"26080397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SMAR1 coordinates HDAC6-mediated deacetylation of Ku70, maintaining Ku70 in a deacetylated state that allows its association with Bax and suppression of Bax mitochondrial translocation (providing radioresistance). Ionizing radiation induces SMAR1 expression and ATM-mediated phosphorylation at Ser370, redistributing SMAR1 to nuclear foci. SMAR1 also facilitates Chk2 phosphorylation to enforce G2/M arrest.\",\n      \"method\": \"Co-immunoprecipitation, chromatin fractionation, acetylation assays, siRNA knockdown, phospho-mutant analysis, irradiation experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple Co-IPs and functional assays; single lab\",\n      \"pmids\": [\"25299772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cdc20, a substrate receptor of the APC/C ubiquitin ligase complex, binds SMAR1 via its D-box motif and promotes K48-linked polyubiquitylation and proteasomal degradation of SMAR1. shRNA-mediated knockdown of Cdc20 stabilizes SMAR1. Genotoxic stress prevents Cdc20-mediated SMAR1 degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay (K48-specific), shRNA knockdown, D-box mutant analysis, proteasome inhibitor experiments\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — polyubiquitylation linkage specificity shown, D-box mutant used, multiple E3 ligases screened, reciprocal Co-IP; well-controlled mechanistic study\",\n      \"pmids\": [\"28617439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SMAR1 binds directly to a MAR site in the IκBα promoter and recruits a corepressor complex to repress IκBα transcription. SMAR1 also inhibits p65 transactivation by producing phosphorylation-deficient NF-κB complexes, downregulating a subset of tumorigenic NF-κB target genes.\",\n      \"method\": \"ChIP, reporter assays, Co-immunoprecipitation, NF-κB target gene array\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and reporter assays with mechanistic pathway dissection; single lab\",\n      \"pmids\": [\"18981184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SMAR1 regulates PKM alternative splicing by recruiting HDAC6 to deacetylate PTBP1, reducing PTBP1 enrichment on PKM pre-mRNA, thereby suppressing PKM2 isoform expression and inhibiting the Warburg effect in cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, CLIP, acetylation assays, qRT-PCR, enzymatic glycolysis assays, in vivo tumor assay\",\n      \"journal\": \"Cancer & metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CLIP demonstrated direct pre-mRNA association, multiple biochemical assays; single lab\",\n      \"pmids\": [\"33863392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SMAR1 negatively regulates STAT3 expression by binding to the MAR element of the STAT3 promoter, adjacent to IL-6 response elements, favoring Foxp3 expression and regulatory T cell differentiation over Th17 differentiation in the context of inflammatory bowel disease.\",\n      \"method\": \"ChIP, T cell-specific conditional SMAR1 knockout mice, colitis models, cytokine assays\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and in vivo conditional knockout with defined immunological phenotype; single lab\",\n      \"pmids\": [\"25993445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SMAR1 functions as a negative regulator of Th1 and Th17 differentiation by recruiting the HDAC1-SMRT complex to MAR regions on the T-bet and IL-17 promoters, thereby repressing their transcription and promoting Th2 cell establishment in the context of allergic airway disease.\",\n      \"method\": \"ChIP, T cell-specific conditional SMAR1 knockout mice, airway inflammation model, cytokine assays\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and conditional KO with defined in vivo phenotype; single lab\",\n      \"pmids\": [\"25736456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SMAR1 inhibits Wnt/β-catenin signaling by recruiting HDAC5 to the β-catenin promoter, reducing its transcription. SMAR1 is itself degraded via its D-box elements ('RCHL' and 'RQRL') in response to aberrant Wnt3a signaling; substitution mutations in these D-box elements completely abrogate proteasomal degradation.\",\n      \"method\": \"ChIP, reporter assays, mutagenesis of D-box elements, isothermal titration calorimetry, in vivo tumor assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, D-box mutagenesis, ITC, in vivo validation; single lab\",\n      \"pmids\": [\"29765542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SMAR1 mRNA is stabilized by Prostaglandin A2 (PGA2) through a stem-loop structure in its 5' UTR (the '1-UTR' form). This stabilization leads to increased SMAR1 protein and subsequent downregulation of Cyclin D1. Breast cancer cell lines harbor a variant 5' UTR ('17-UTR') lacking this stem-loop, making SMAR1 mRNA non-responsive to PGA2 stabilization.\",\n      \"method\": \"RNA EMSA, 5' UTR deletion/mutation constructs, reporter assays, RT-PCR quantification\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA structural element functionally mapped by mutagenesis; single lab\",\n      \"pmids\": [\"17726044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HSP70 binds to a novel site in the 5' UTR of SMAR1 (the phi1 form) upon PGA2 treatment, stabilizing the wild-type SMAR1 transcript and increasing protein levels, contributing to PGA2-mediated cell cycle arrest. HSP70 cannot bind the phi17 variant 5' UTR present in breast cancer cells.\",\n      \"method\": \"RNA pulldown/RIP assays, HSP70 knockdown, mRNA stability assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct RNA-protein interaction demonstrated; mechanistic consequence shown by knockdown; single lab\",\n      \"pmids\": [\"20153327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TNFα stimulation induces phosphorylation of SMAR1 at Ser-347, promoting its cytoplasmic translocation and releasing its negative regulation of CD40 transcription. Simultaneously, TNFα-induced JAK1-mediated phosphorylation of STAT1 at Tyr-701 enables STAT1 nuclear translocation and CD40 activation via p300 recruitment and histone H3 acetylation.\",\n      \"method\": \"Phospho-specific detection, subcellular fractionation, ChIP, reporter assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — phosphorylation-dependent localization change mechanistically linked to target gene regulation; single lab\",\n      \"pmids\": [\"20006573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BANP promotes p53 phosphorylation and nuclear retention in vascular endothelial cells exposed to chronic intermittent hypoxia, inducing cellular senescence. BANP overexpression alone was sufficient to induce senescence.\",\n      \"method\": \"BANP overexpression in HUVECs, EdU assay, cell cycle analysis, SA-β-gal staining, Western blot for p53/p21, in vivo CIH rat model\",\n      \"journal\": \"Gerontology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — gain-of-function with phenotypic readout but limited mechanistic dissection of BANP-p53 interaction; single lab\",\n      \"pmids\": [\"38168028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ZNF471 interacts with BANP in renal cell carcinoma cells and suppresses the PI3K/AKT/mTOR signaling pathway to inhibit cancer malignancy.\",\n      \"method\": \"Co-immunoprecipitation, signaling pathway analysis, functional cell biology assays\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP, pathway placement based on inhibitor/western blot; limited mechanistic detail\",\n      \"pmids\": [\"38169650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SMAR1 inhibits p53 acetylation and p53-dependent apoptosis by repressing p300 expression and by interacting with the p53-p300 transcriptional complex to antagonize p300-p53 interaction, thereby suppressing activation of p53 apoptotic targets and miR-34a.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, siRNA knockdown, Western blot\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — mechanistic dissection by Co-IP and functional rescue; single lab\",\n      \"pmids\": [\"22074660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SMAR1 expression in breast cancer stem cells is repressed by cooperative interaction of pluripotency factors Oct4 and Sox2 with HDAC1 at the SMAR1 promoter. Conversely, SMAR1 suppresses ABCG2 transcription by recruiting HDAC2 to the ABCG2 promoter, sensitizing cancer stem cells to chemotherapy.\",\n      \"method\": \"ChIP, Co-immunoprecipitation, reporter assays, shRNA, in vivo tumor model\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and Co-IP with functional in vivo validation; single lab\",\n      \"pmids\": [\"33082288\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BANP/SMAR1 is a BEN domain-containing transcription factor and nuclear matrix-associated protein that binds unmethylated CGCG motifs (Banp motif) at CpG island promoters—a process structurally dependent on BEN domain oligomerization—to open chromatin, phase nucleosomes, and activate essential metabolic and cell-cycle genes; its binding is epigenetically gated by CpG methylation. BANP also functions as a transcriptional repressor by recruiting HDAC1/SIN3, HDAC6, or HDAC5 corepressor complexes to MAR elements at target promoters (cyclin D1, Slug, β-catenin, STAT3, IκBα, among others), and it stabilizes and activates p53 through direct interaction via its RS domain while blocking MDM2-mediated degradation; it additionally modulates alternative splicing by maintaining Sam68 and PTBP1 in a deacetylated state via HDAC6, and is itself subject to proteasomal degradation via APC/C-Cdc20-mediated K48-linked polyubiquitylation at its D-box motifs.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BANP (also known as SMAR1) is a BEN domain-containing transcription factor that functions as both a sequence-specific activator at unmethylated CpG island promoters and an HDAC-dependent repressor at MAR elements, thereby coordinating essential metabolic gene expression, cell-cycle control, p53 signaling, alternative splicing, and T helper cell differentiation. BANP binds unmethylated CGCG motifs at CpG island promoters through its BEN domain, where oligomerization is required for methylation-sensitive substrate selection, leading to chromatin opening, nucleosome phasing, and activation of essential metabolic and DNA replication genes [PMID:34234345, PMID:39225042, PMID:35942692]. At MAR elements, BANP recruits HDAC1/SIN3, HDAC5, or HDAC6 corepressor complexes to repress target promoters including cyclin D1, Slug, β-catenin, STAT3, IκBα, and T-bet, and it modulates alternative splicing of CD44 and PKM pre-mRNAs by maintaining the splicing regulators Sam68 and PTBP1 in a deacetylated state via HDAC6 [PMID:16166625, PMID:25086032, PMID:26080397, PMID:33863392, PMID:25993445]. BANP stabilizes and activates p53 through direct interaction via its RS domain while blocking MDM2-mediated degradation, and during post-stress recovery it participates in a ternary complex with MDM2 and phospho-p53 that recruits HDAC1 to deacetylate p53 and terminate the stress response; BANP itself is subject to APC/C–Cdc20-mediated K48-linked polyubiquitylation and proteasomal degradation [PMID:15701641, PMID:19303885, PMID:28617439].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of BANP as a MAR-binding nuclear protein at the TCRβ locus established its fundamental DNA-binding specificity for scaffold/matrix-associated regions, providing the initial molecular handle for subsequent functional studies.\",\n      \"evidence\": \"EMSA and GST-pulldown with MARβ DNA, RT-PCR for tissue expression, and chromosomal mapping in mouse\",\n      \"pmids\": [\"10950932\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MAR-binding specificity shown by competition only, without genome-wide binding data\", \"functional consequence of MAR binding at TCRβ not yet demonstrated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that BANP physically interacts with p53 and activates p53-dependent transcription linked this MAR-binding protein to the central tumor suppressor pathway, explaining its anti-proliferative activity.\",\n      \"evidence\": \"Co-immunoprecipitation, reporter assays, cell cycle analysis, and in vivo tumor growth delay upon SMAR1(S) overexpression\",\n      \"pmids\": [\"12494467\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"domain of interaction with p53 not yet mapped\", \"mechanism of p53 stabilization unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping of the RS domain as the p53-interaction and stabilization interface, and identification of PKC-mediated phosphorylation at Ser347 as essential for this activity, defined the molecular basis of BANP-p53 signaling and revealed that BANP blocks MDM2-mediated p53 degradation.\",\n      \"evidence\": \"Domain deletion/mutagenesis, in vitro kinase assays, Co-IP, siRNA, and SMAR1 transgenic mice\",\n      \"pmids\": [\"15701641\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis of RS domain–p53 interaction not resolved\", \"whether PKC isoform selectivity matters in vivo is untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that BANP represses cyclin D1 by recruiting the SIN3/HDAC1 complex to its promoter MAR element established the paradigm of BANP as an HDAC-dependent transcriptional repressor acting through MAR sites.\",\n      \"evidence\": \"ChIP, Co-IP, reporter assays, siRNA knockdown showing HDAC1 recruitment and histone deacetylation spreading over 5 kb\",\n      \"pmids\": [\"16166625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether BANP recruits additional corepressor subunits besides SIN3/HDAC1 at this locus was unknown\", \"genome-wide extent of MAR-dependent repression not mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extension of the MAR-dependent repression model to the IκBα promoter and demonstration that BANP inhibits NF-κB transactivation broadened its role to inflammatory signaling regulation.\",\n      \"evidence\": \"ChIP at the IκBα MAR site, reporter assays, NF-κB target gene array\",\n      \"pmids\": [\"18981184\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"identity of the corepressor complex at the IκBα promoter not specified\", \"not confirmed in primary immune cells\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of a ternary BANP–MDM2–phospho-p53 complex that recruits HDAC1 to deacetylate p53 during post-stress recovery revealed that BANP acts as a molecular switch to terminate the p53 response, resolving the paradox of how BANP both activates and attenuates p53.\",\n      \"evidence\": \"Co-IP of ternary complex, ChIP at p21 promoter, cell cycle kinetics after stress recovery\",\n      \"pmids\": [\"19303885\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"temporal dynamics of complex assembly not quantified\", \"whether this switch operates in non-transformed cells in vivo is untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The finding that severe DNA damage sequesters BANP into PML nuclear bodies—releasing its repression of BAX/PUMA—provided a mechanism for how damage severity is decoded to choose between cell-cycle arrest and apoptosis.\",\n      \"evidence\": \"ChIP, PML body imaging, reporter assays, SMAR1 mutant analysis in cells with graded DNA damage\",\n      \"pmids\": [\"20075864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"signals controlling PML body sequestration of BANP not identified\", \"whether this mechanism operates in vivo tissue homeostasis is unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstration that BANP inhibits EMT by both transcriptionally repressing Slug via HDAC1 and stabilizing E-cadherin protein by blocking MDM2-mediated ubiquitination revealed a dual-level anti-metastatic mechanism.\",\n      \"evidence\": \"ChIP at Slug promoter MAR, Co-IP, ubiquitination assay, migration assay in breast cancer cells\",\n      \"pmids\": [\"25086032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether BANP directly contacts MDM2 at E-cadherin or acts indirectly is unresolved\", \"in vivo metastasis suppression via this dual mechanism not shown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that BANP regulates alternative splicing by maintaining Sam68 in a deacetylated state via HDAC6, with ERK1/2-mediated phosphorylation of BANP causing cytoplasmic translocation and release of splicing regulation, established a non-transcriptional function and a signaling-dependent toggle mechanism.\",\n      \"evidence\": \"Co-IP, CLIP, phosphorylation site mutagenesis, alternative splicing assays for CD44, in vivo metastasis model\",\n      \"pmids\": [\"26080397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"full repertoire of BANP-regulated alternative splicing events not catalogued\", \"direct structural basis of BANP–Sam68 interaction unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional T cell-specific BANP knockout revealed its role in repressing Th1/Th17 differentiation by recruiting HDAC1-SMRT to T-bet/IL-17 promoters and in repressing STAT3 to favor Foxp3+ Treg differentiation, establishing BANP as a key regulator of T helper cell fate.\",\n      \"evidence\": \"ChIP at T-bet, IL-17, and STAT3 promoters; conditional KO mice in colitis and airway inflammation models\",\n      \"pmids\": [\"25993445\", \"25736456\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"whether BANP binds MAR or CGCG motifs at these immune gene promoters is not distinguished\", \"human immunological relevance not confirmed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of APC/C–Cdc20 as the E3 ligase that targets BANP for K48-linked polyubiquitylation via D-box motifs explained how BANP protein levels are dynamically controlled, with genotoxic stress blocking this degradation to stabilize BANP.\",\n      \"evidence\": \"Co-IP, K48-specific ubiquitination assay, D-box mutant analysis, proteasome inhibitor experiments, shRNA of Cdc20\",\n      \"pmids\": [\"28617439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"cell-cycle phase dependence of APC/C–Cdc20-mediated BANP turnover not determined\", \"whether D-box degradation interfaces with the Wnt-induced degradation pathway is unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Genome-wide identification of BANP as the transcription factor for the CGCG (Banp) motif at CpG island promoters, with methylation-gated binding leading to chromatin opening and activation of essential metabolic genes, fundamentally reframed BANP from a MAR-binding repressor to a dual-function activator/repressor whose binding is epigenetically regulated.\",\n      \"evidence\": \"Single-molecule footprinting, interaction proteomics, ChIP-seq, in vitro binding with methylated/unmethylated substrates in mouse ES cells and neurons\",\n      \"pmids\": [\"34234345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how BANP activation at CpG islands and repression at MARs are coordinated genome-wide is unresolved\", \"whether BANP is essential in adult tissues beyond development unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Zebrafish genetic studies demonstrated that Banp directly activates DNA replication and chromosome segregation genes (wrnip1, cenpt, ncapg) via the Banp motif, and its loss triggers replication stress, p53-dependent apoptosis, and prolonged M-phase, validating the essential in vivo role predicted by the CpG island activation model.\",\n      \"evidence\": \"banp mutant and morphant zebrafish, RNA-seq, ATAC-seq, epistasis with tp53\",\n      \"pmids\": [\"35942692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mammalian in vivo validation of these specific target genes is lacking\", \"whether Banp loss phenotypes are fully p53-dependent is unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Crystal structures of the BANP BEN domain in apo and DNA-bound forms revealed electrostatic DNA contacts with base-specific recognition at TC motifs, but showed comparable affinity for methylated and unmethylated DNA by the isolated domain, creating a mechanistic puzzle about methylation selectivity.\",\n      \"evidence\": \"X-ray crystallography, ITC, protein binding microarray, site-directed mutagenesis\",\n      \"pmids\": [\"37086783\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"discrepancy between isolated domain and full-length protein methylation sensitivity unresolved at this point\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Follow-up crystal structures resolved the methylation-selectivity puzzle by showing that BEN domain oligomerization is required for preferential binding of unmethylated CGCG substrates, establishing the structural basis for BANP's role as a CpG island-specific transcription factor.\",\n      \"evidence\": \"X-ray crystallography of BEN domain–DNA complexes with oligomerization analysis\",\n      \"pmids\": [\"39225042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"full-length BANP structure not determined\", \"oligomeric state in vivo not confirmed\", \"how oligomerization interfaces with chromatin context is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include how BANP's dual roles as a CpG island activator and MAR-dependent repressor are coordinated at the genome-wide level, what determines target selection between these two modes, and whether BANP is essential in adult mammalian tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"no genome-wide integration of activator and repressor binding profiles\", \"no conditional knockout phenotype in adult mammals\", \"no full-length BANP structure or structural model of BANP bound to MAR DNA\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 4, 7, 11, 12, 19, 21, 22]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 7, 11, 15, 21, 22, 23, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 7, 8, 11, 16, 17]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 3, 7, 15, 21, 22, 23, 30]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 7, 11, 12]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 6, 7, 17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 17]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [16, 20]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [19, 23]}\n    ],\n    \"complexes\": [\n      \"SIN3/HDAC1 corepressor complex\",\n      \"SMAR1-HDAC6-Sam68 complex\",\n      \"SMAR1-MDM2-p53 ternary complex\"\n    ],\n    \"partners\": [\n      \"TP53\",\n      \"MDM2\",\n      \"HDAC1\",\n      \"HDAC6\",\n      \"HDAC5\",\n      \"KHDRBS1\",\n      \"CDC20\",\n      \"PTBP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}